Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Canaccord Genuity Starts Physicians Realty Trust (DOC) at Buy
-
Canaccord Genuity Cuts Price Target on ARM Holdings plc (ARMH) Following Soft Android Smartphone Sales
-
Canaccord Genuity Survey Shows Apple (AAPL) iPhone Maintaining Strong High-End Share Despite Global Smartphone Weakness
-
Atara Biotherapeutics (ATRA) Announces $125M Common Stock Offering
-
Atara Bio Announces Proposed Offering of Common Stock
-
ConforMIS Closes Initial Public Offering
-
ConforMIS Closes Initial Public Offering
-
Canaccord Genuity Reiterates Buy on Trupanion (TRUP) Following Survey Results
-
Canaccord Genuity Remains Bullish after Meeting with Level 3 Communications (LVLT) Management
-
Canaccord Genuity Raises Price Target on Versartis (VSAR) as Partial Clinical Hold is Lifted
-
EnteroMedics (ETRM) Prices 32M Common Stock, Warrants Unit Offering at 50c/Unit
-
EnteroMedics Inc. Announces Pricing of $16.0 Million Public Offering of Common Stock and Warrants
-
DHX Media (DHXM) Commences 8.7M Share Offering
-
DHX Media Ltd. Announces Launch of Proposed Public Offering of Shares
-
EnteroMedics (ETRM) Announces Common Stock, Warrants Offering
-
EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants
-
EnteroMedics Inc. Announces Termination of Public Offering of Common Stock and Warrants
-
Bee Vectoring Technologies International Inc. (Formerly Unique Resources Corp.) Announces Commencement of Trading on the TSXV Following Closing of Its Reverse Takeover
-
EMED Mining Public Limited: Notice of AGM
-
EMED Mining Public Limited: Director Share Purchase
-
Canaccord Genuity Cuts Price Target on Xenon Pharmaceuticals (XENE) Following TV-45070 Study
-
Canaccord Genuity Raised Price Target on KemPharm (KMPH) Ahead of KP201 Data
-
Seres Therapeutics Announces Closing of Initial Public Offering
-
ConforMIS (CFMS) IPO Opens Up 20%
-
UPDATE: Canaccord Genuity Starts Aldeyra Therapeutics (ALDX) at Buy
-
Canaccord Genuity Reiterates Hold Following AeroVironment's (AVAV) 4Q15 Results
-
ConforMIS (CFMS) Prices 9M Common Stock IPO at $15/Share
-
Egalet to Present at Upcoming Conferences This Summer
-
EMED Mining Public Limited: Quarterly Financial Statements
-
ConforMIS Announces Pricing of Its Initial Public Offering
-
ConforMIS Announces Pricing of Its Initial Public Offering
-
Unique Resources Corp. Announces Closing of its Private Placement and Reverse Takeover and Name Change to Bee Vectoring Technologies International Inc.
-
Zynerba Files Registration Statement for Proposed Initial Public Offering of Common Stock
-
Zynerba Pharmaceuticals (ZYNE) Files $57.5M Common Stock IPO
-
EMED Mining Public Limited: Posting of Annual Report
-
Vernalis plc - Appointment of Non-Executive Director
-
UPDATE: Canaccord Genuity Starts Shopify (SHOP) at Hold
-
UPDATE: Canaccord Genuity Starts Bill Barrett (BBG) at Buy
-
UPDATE: Canaccord Genuity Starts Bonanza Creek Energy (BCEI) at Buy
-
UPDATE: Canaccord Genuity Starts PDC Energy (PDCE) at Buy
-
Goldcorp announces closing of secondary offering of shares of Tahoe Resources
-
Tahoe Resources Announces Closing Of Secondary Offering By Goldcorp Inc.
-
EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants
-
UPDATE: Cantor Fitzgerald Starts Intersect ENT (XENT) at Buy
-
EnteroMedics (ETRM) Announces Common Units Offering
-
EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants
-
Canaccord Genuity Maintains Buy on IDEXX Labs (IDXX) Following Investor Meetings
-
Alpha Peak Announces Completion of Qualifying Transaction
-
Seres Therapeutics (MCRB) IPO Opens Up 58%
-
Canaccord Genuity Maintains a Hold Rating on Nike (NKE) Following 15c EPS Beat

